Clinical Trials
3 trialsNCT04552418 2024-02-28
Intestinal Microbiome Modification With Resistant Starch in Patients Treated With Dual Immune Checkpoint Inhibitors
University of Michigan Rogel Cancer Center
Phase EARLY_PHASE1 Completed
NCT05126927 2023-04-12
A PET Imaging Agent to Assess the Level of Tumor Tissue-infiltrating CD8 + T Cells in Patients With Solid Tumors
SmartNuclide Biopharma
Phase EARLY_PHASE1 Completed
NCT04046016 2019-08-06
A Study Using Whole-body PET After Oral Microdose of 18F-labeled Liporaxel in Patients With Solid Tumor
Seoul National University Hospital
Phase EARLY_PHASE1 Completed